TMCnet News
Dendrimers and Polymer Drug Conjugates Market (2016 - 2026) - 40 Polymer Drug Conjugates in Clinical Development - Research and MarketsResearch and Markets has announced the addition of the "Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026" report to their offering. The report delivers a comprehensive study on the emergence of nanocarriers as a significant tool for drug delivery, therapeutics and diagnostics. For the purpose of this report, we have primarily focused on the following two types of nanocarriers.
Nearly 40 polymer drug conjugates are currently in clinical and preclinical stages of development; molecules in phase III and II account for nearly 19% of the pipeline while 26% is captured by molecules in phase I/II and I. There are several types of dendrimers being used for both commercial and research purposes in the pharmaceutical domain; the dendrimers most widely used for industry applications include PAMAM, PLL, Priostar®, Astramol®. However, with over 4000 papers published between 2006 and 2016 (as reported in PubMed), dendrimers are being extensively explored by researchers in the non-industry / academic institutes. Specific molecules such as NKTR-181 and NKTR-102 are anticipated to achieve a block buster status in the near future. With eight molecules (two mentioned above and six others in lower stages of development) in development, Nektar Therapeutics is expected to play an important role in the market's evolution. The market of dendrimers is still in its infancy within the biomedical sector. The domain is gradually gaining traction with several technologies and approaches being designed for improving drug release properties. In addition to drug delivery, which is the key application area, some other potential applications of dendrimers being actively pursued in research include disease diagnosis, targeted therapy, MRI imaging, tissue regeneration, cell repair and vaccine development. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Dendrimers: A Detailed Review 6. Polymer Drug Conjugates: Drug Profiles 7. Market Forecast And Opportunity Analysis 8.Conclusion Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/3kql5t/dendrimers_and View source version on businesswire.com: http://www.businesswire.com/news/home/20160704005521/en/ |
